REGULATORY APPROVAL

APPROVED: EMD Receives Authorisation to Prescribe MDMA for Therapy

Next Investors Jan 10, 2024

Today, EMD’s specialist was granted “Authorised Prescriber Status” for its MDMA assisted therapy for PTSD

Earlier than Expected - DXB Gets First Regulatory Approval in Europe.

Next Investors Feb 01, 2022

Dimerix (ASX:DXB) just delivered significant progress on its Phase III Clinical Trial for FSGS, with the first EU regulatory approval given for DXB’s kidney disease study in Denmark... earlier than expected.

Earlier than Expected - DXB Gets First Regulatory Approval in Europe.

Finfeed Feb 01, 2022

Dimerix (ASX:DXB) just delivered significant progress on its Phase III Clinical Trial for FSGS, with the first EU regulatory approval given for DXB’s kidney disease study in Denmark... earlier than expected.